Same Indication

Pembrolizumab vs Simvastatin

Pembrolizumab vs Simvastatin: Overview

This comparison examines the pharmacological differences between Pembrolizumab and Simvastatin.

Mechanism of Action

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Simvastatin: Prodrug converted to active form that inhibits HMG-CoA reductase.

Pharmacokinetics

Half-life: Pembrolizumab — 26 days; Simvastatin — 2 hours.

Chemical Properties

Molecular Formula: Simvastatin — C25H38O5.

Molecular Weight: Simvastatin — 418.5700 g/mol.

Type: Pembrolizumab — Antibody; Simvastatin — Small molecule.